ConductScience.org, home

Paper40657643

Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases.

Bi S and 6 others. Front Pharmacol, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases. Papers, record 40657643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40657643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases.
PubMed
Journal
Front Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.77, provisional
iCite
Revised in PubMed
2025-07-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bi SShijun
2Liu SShibing
3Zhu KKunyuan
4Gao DDandan
5Chen LLigang
6Yu CChunyong
7Liang GGuobiao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121992896Salvianolic acid B suppresses IFN-γ-induced JAK/STAT1 activation in endothelial cells.Thromb Res2011https://conductscience.org/library/papers/21992896PubMed
236826049Neuroprotective Effects of Geopung-Chunghyuldan Based on Its Salvianolic Acid B Content Using an In Vivo Stroke Model.Curr Issues Mol Biol2023https://conductscience.org/library/papers/36826049PubMed
325981395Salvianolic acid B attenuates apoptosis and inflammation via SIRT1 activation in experimental stroke rats.Brain Res Bull2015https://conductscience.org/library/papers/25981395PubMed
429180227Mechanism of salvianolic acid B neuroprotection against ischemia/reperfusion induced cerebral injury.Brain Res2018https://conductscience.org/library/papers/29180227PubMed
533994527Salvianolic acid B protects against MPP+-induced neuronal injury via repressing oxidative stress and restoring mitochondrial function.Neuroreport2021https://conductscience.org/library/papers/33994527PubMed
624780446Salvianolic acid B protects human endothelial progenitor cells against oxidative stress-mediated dysfunction by modulating Akt/mTOR/4EBP1, p38 MAPK/ATF2, and ERK1/2 signaling pathways.Biochem Pharmacol2014https://conductscience.org/library/papers/24780446PubMed
732516126Salvianolic Acid B improves cognitive impairment by inhibiting neuroinflammation and decreasing Aβ level in Porphyromonas gingivalis-infected mice.Aging (Albany NY)2020https://conductscience.org/library/papers/32516126PubMed
837904689Neuroprotective mechanism of salvianolic acid B against cerebral ischemia-reperfusion injury in mice through downregulation of TLR4, p-p38MAPK, p-JNK, NF-κB, and IL-1β.Immun Inflamm Dis2023https://conductscience.org/library/papers/37904689PubMed
916440326Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta.J Cell Biochem2006https://conductscience.org/library/papers/16440326PubMed
1026595643Vascular dementia.Lancet2015https://conductscience.org/library/papers/26595643PubMed
1111742594Salvianolic acid B inhibits fibril formation and neurotoxicity of amyloid beta-protein in vitro.Acta Pharmacol Sin2001https://conductscience.org/library/papers/11742594PubMed
1239697159Interleukin-3 Modulates Macrophage Phagocytic Activity and Promotes Spinal Cord Injury Repair.CNS Neurosci Ther2024https://conductscience.org/library/papers/39697159PubMed
1337708947The potential effect of salvianolic acid B against rat ischemic brain injury in combination with mesenchymal stem cells.J Chem Neuroanat2023https://conductscience.org/library/papers/37708947PubMed
1437564636Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage.Front Immunol2023https://conductscience.org/library/papers/37564636PubMed
1529551684Salvianolic acid B attenuates mitochondrial stress against Aβ toxicity in primary cultured mouse neurons.Biochem Biophys Res Commun2018https://conductscience.org/library/papers/29551684PubMed
1627258307Salvianolic Acid B Inhibits Aβ Generation by Modulating BACE1 Activity in SH-SY5Y-APPsw Cells.Nutrients2016https://conductscience.org/library/papers/27258307PubMed
1737913602Salvianolic acid B exerts protective effects against Aβ-induced neuroinflammation through the inhibition of NLRP3 inflammasome activation and switching of M1/M2 polarization.Tissue Cell2023https://conductscience.org/library/papers/37913602PubMed
1829257241Salvianolic acid B recovers cognitive deficits and angiogenesis in a cerebral small vessel disease rat model via the STAT3/VEGF signaling pathway.Mol Med Rep2018https://conductscience.org/library/papers/29257241PubMed
1922545124Direct stimulation of adult neural stem/progenitor cells in vitro and neurogenesis in vivo by salvianolic acid B.PLoS One2012https://conductscience.org/library/papers/22545124PubMed
2029212498Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome.J Neuroinflammation2017https://conductscience.org/library/papers/29212498PubMed

See all 71 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42481908A Study on the Effects of Intranasally Administered Liquid Crystalline Nanoparticles Loaded with Salvianolic Acid B in Vascular Dementia.Mol Neurobiol2026https://conductscience.org/library/papers/42481908PubMed
42191896T cell-targeted immunotherapies for multiple sclerosis: molecular mechanisms to therapeutic perspectives from Traditional Chinese medicine.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42191896PubMed
42123431Distinct Molecular Mechanisms Underlie Modulation of Seeded α-Synuclein Aggregation and Toxicity by Salvianolic Acid B and Dihydromyricetin.Int J Mol Sci2026https://conductscience.org/library/papers/42123431PubMed
42004599The "habitat-phytochemistry-pharmacological effect" nexus: a multidimensional review of ethnomedicinal Salvia in China.Front Pharmacol2026https://conductscience.org/library/papers/42004599PubMed
41948424Potential correlation between chronic pain and amyloid beta in Alzheimer's disease.Front Pain Res (Lausanne)2026https://conductscience.org/library/papers/41948424PubMed
41788408Systems-level molecular and immunological evidence identifies Th17/Treg modulation as a key mechanism of CRSJ's neuroprotection in Parkinson's disease.Front Aging Neurosci2026https://conductscience.org/library/papers/41788408PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40657643

GET https://conductscience.org/api/papers/v1/40657643/references?page=2